Streetbeat News

Revenues

COSM

Cosmos Health has secured exclusive distribution rights for Mpox virus PCR detection kits in Greece and Cyprus, and non-exclusive rights across Europe. This strategic move could enhance their market presence and revenue potential in the healthcare sector.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 2:25 pm

TCNNF

The battle over Florida's cannabis legalization initiative, Amendment 3, is heating up. The pro-cannabis campaign, led by Smart and Safe Florida, has raised $71.8 million, largely from Trulieve, while opposition PACs have raised $14.5 million, bolstered by Ken Griffin's $12 million donation. Polls show mixed support for the amendment.

Portfolio Pulse from Maureen Meehan

August 21, 2024 | 2:23 pm

VVX

V2X shares surged following the announcement of a significant U.S. Army task order worth $3.7 billion over five years.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 2:20 pm

TGT

ULTA

Ulta Beauty shares are experiencing an uptick following Target's positive Q2 financial results. Target's partnership with Ulta Beauty, offering its products both online and in physical stores, is likely contributing to this positive movement.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 2:14 pm

JD

TGT

WMT

Walmart shares are trading higher following Target's strong Q2 results, which exceeded expectations and led to an increased profit outlook. Walmart is also divesting its stake in JD.com to focus on its operations in China, aiming to raise $3.74 billion.

Portfolio Pulse from Nabaparna Bhattacharya

August 21, 2024 | 2:08 pm

CRKN

Crown Electrokinetics' new division, Element 82, has secured service projects in Florida and New York, potentially boosting the company's growth and market presence.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 2:01 pm

CLGN

CollPlant Biotechnologies (NASDAQ:CLGN) has been evaluated by 4 analysts over the past three months, all giving bullish ratings. The average 12-month price target is $12.5, up from $12. Analysts from HC Wainwright & Co. and EF Hutton maintain 'Buy' ratings with price targets of $11 and $14, respectively. Despite a strong market presence, CollPlant faces revenue challenges with a significant decline in growth, but maintains a strong net margin and ROE.

Portfolio Pulse from Benzinga Insights

August 21, 2024 | 2:00 pm

ANF

Abercrombie & Fitch (NYSE:ANF) has been analyzed by 9 analysts, showing a range of ratings from bullish to bearish. The average 12-month price target has increased by 21.79% to $188.78. Analysts have adjusted their ratings and price targets, reflecting positive sentiment and strong financial performance, including a 22.1% revenue growth rate and a net margin of 11.15%.

Portfolio Pulse from Benzinga Insights

August 21, 2024 | 2:00 pm

SGC

Analysts have mixed ratings for Superior Gr of Cos (NASDAQ:SGC), with recent evaluations showing a slight decrease in average price targets. The company's financials indicate strong performance in revenue growth, net margin, ROE, and ROA, with prudent debt management.

Portfolio Pulse from Benzinga Insights

August 21, 2024 | 2:00 pm

KSS

Analysts have provided a range of ratings for Kohl's (NYSE:KSS) over the past three months, with a decrease in the average 12-month price target from $27.29 to $24.00. Recent analyst actions include several downgrades and lowered price targets, reflecting changing market conditions and company performance. Kohl's faces challenges with declining revenue and below-average ROE and ROA, but maintains a strong net margin and a healthy debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

August 21, 2024 | 2:00 pm